GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Coral Laboratories Ltd (BOM:524506) » Definitions » Net Income Including Noncontrolling Interests

Coral Laboratories (BOM:524506) Net Income Including Noncontrolling Interests : ₹242 Mil (TTM As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Coral Laboratories Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Coral Laboratories's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was ₹28 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was ₹242 Mil.


Coral Laboratories Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Coral Laboratories's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coral Laboratories Net Income Including Noncontrolling Interests Chart

Coral Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 135.55 90.46 64.45 157.89 241.56

Coral Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.87 88.04 63.80 61.45 28.27

Coral Laboratories Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹242 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coral Laboratories Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Coral Laboratories's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


Coral Laboratories Business Description

Industry
Traded in Other Exchanges
N/A
Address
Lal Bahadur Shastri Road, No. 3-B, Patanwala Industrial Estate, Opposite Shreyas Cinema, Ghatkopar (West), Mumbai, MH, IND, 400086
Coral Laboratories Ltd is engaged in the pharmaceutical business. The company is involved in the formulation of medicines. The company's dosage form includes tablets, capsules, liquid orals, b-lactam, dry syrup, meter dose inhalers, injectables, drops, sprays, special kits, and others. Its geographical segments include Ethiopia, India, and the Rest of the world.

Coral Laboratories Headlines

No Headlines